Form 4 for MRNA Moderna
Accepted 2023-10-10 00:00:00 ET · period of report 2023-10-05 · accession 0001127602-23-025714 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-10 | 2023-10-05 | MRNA | Mock James M | CFO | M - OptEx | — | +5,810 | 5,810 | New | — |
| D | 2023-10-10 | 2023-10-06 | MRNA | Mock James M | CFO | S - Sale+OE | $102.50 | -2,858 | 2,952 | -49% | -$292.9K |
| D | 2023-10-10 | 2023-10-05 | MRNA | Mock James M | CFO | M - OptEx | $0.00 | -5,810 | 17.4K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-05 | M | A | 5,810 | — | 5,810 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2023-10-06 | S | D | 2,858 | $102.50 | 2,952 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-10-05 | M | D | 5,810 | $0.00 | 17,432 | D | — · — to — | 5,810 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |